Profil
Dr. Riccardo Palmisano, MD, is a Senior Advisor at Triton Advisers (UK) Ltd., a Healthcare Venture Partner at Innogest SGR SpA and a Senior Advisor at Quadrivio Group SpA. He is on the Board of Directors at Genenta Science SpA. Dr. Palmisano was previously employed as a Chief Executive Officer by Innovavector Srl, an Executive Director by AGC Biologics SpA, a Director-Business Development & Strategy by Sanofi SpA, a Vice President & General Manager-Italy by Genzyme Corp., a Vice President-Commercial Retail Market by GlaxoSmithKline SpA, a General Manager by Istituto Luso Farmaco d'Italia SpA, a Director-Pharmaceutical Division by A.Menarini Industrie Farmaceutiche Riunite Srl, a Chairman by Betaglue Technologies SpA, and a Vice President by Cluster Lombardo Scienze Della Vita.
He also served on the board at Assobiotec.
He received his doctorate degree from the University of Parma.
Postes actifs de Riccardo Palmisano
| Sociétés | Poste | Début |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Directeur/Membre du Conseil | 29/06/2026 |
Innogest SGR SpA
Innogest SGR SpA Investment ManagersFinance Innogest,invests in companies located in Italy and Europe. The firm targets companies operating in the fields of health and electronic technology with particular focus for biotech, healthcare and IT services. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Quadrivio Group SpA
Quadrivio Group SpA Investment ManagersFinance Q Group invests in SMEs located in Italy and Europe. The firm targets companies operating in the fields of the industrial, manufacturing, electronic technology, consumer, apparel, consumer sundries, home furnishing and food sector. It provides financing for buyout and acquisition transactions. It also takes majority stake in company. | Consultant / Advisor | - |
Triton Investment Management Ltd.
Triton Investment Management Ltd. Investment ManagersFinance Triton Partners invests in small and mid-market companies located in Europe with an enterprise value of EUR 70 - 2000 million. The firm targets companies operating in the fields of business services, industrial tech and healthcare sectors. It provides financing in the form of debt and equity for growth and buyouts transactions with an investment size of EUR 30 - 500 million. | Consultant / Advisor | 01/01/2022 |
Anciens postes connus de Riccardo Palmisano
| Sociétés | Poste | Fin |
|---|---|---|
Innovavector Srl
Innovavector Srl Miscellaneous Commercial ServicesCommercial Services Engages in designing and testing production techniques, purification and quality control of adeno-associated viral vectors | Directeur Général | 01/02/2025 |
Sanofi Srl
Sanofi Srl Pharmaceuticals: MajorHealth Technology Engages in research, development, manufacture and distributes therapeutic solutions | Corporate Officer/Principal | 01/01/2013 |
Betaglue Technologies SpA
Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company that manufacture oncology therapeutic products | Président | - |
Cluster Lombardo Scienze Della Vita | Corporate Officer/Principal | - |
Assobiotec
Assobiotec Miscellaneous Commercial ServicesCommercial Services Operates as professional association for the development of biotechnology | Président | - |
Formation de Riccardo Palmisano
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
AGC Biologics SpA
AGC Biologics SpA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services for protein-based biologics, cells & gene therapies and messenger RNA | Health Technology |
Triton Investment Management Ltd.
Triton Investment Management Ltd. Investment ManagersFinance Triton Partners invests in small and mid-market companies located in Europe with an enterprise value of EUR 70 - 2000 million. The firm targets companies operating in the fields of business services, industrial tech and healthcare sectors. It provides financing in the form of debt and equity for growth and buyouts transactions with an investment size of EUR 30 - 500 million. | Finance |
A. Menarini Industrie Farmaceutiche Riunite SRL
A. Menarini Industrie Farmaceutiche Riunite SRL Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and diagnostics company | Health Technology |
GlaxoSmithKline SpA
GlaxoSmithKline SpA Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products, vaccines and health products | Health Technology |
Innogest SGR SpA
Innogest SGR SpA Investment ManagersFinance Innogest,invests in companies located in Italy and Europe. The firm targets companies operating in the fields of health and electronic technology with particular focus for biotech, healthcare and IT services. It provides financing for early stage capital requirements. | Finance |
University of Parma
University of Parma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Istituto Luso Farmaco d'Italia SpA
Istituto Luso Farmaco d'Italia SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sanofi Srl
Sanofi Srl Pharmaceuticals: MajorHealth Technology Engages in research, development, manufacture and distributes therapeutic solutions | Health Technology |
Assobiotec
Assobiotec Miscellaneous Commercial ServicesCommercial Services Operates as professional association for the development of biotechnology | Commercial Services |
Quadrivio Group SpA
Quadrivio Group SpA Investment ManagersFinance Q Group invests in SMEs located in Italy and Europe. The firm targets companies operating in the fields of the industrial, manufacturing, electronic technology, consumer, apparel, consumer sundries, home furnishing and food sector. It provides financing for buyout and acquisition transactions. It also takes majority stake in company. | Finance |
Genenta Science SpA
Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
Betaglue Technologies SpA
Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company that manufacture oncology therapeutic products | Commercial Services |
Innovavector Srl
Innovavector Srl Miscellaneous Commercial ServicesCommercial Services Engages in designing and testing production techniques, purification and quality control of adeno-associated viral vectors | Commercial Services |
Cluster Lombardo Scienze Della Vita |
















